Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1170082 | 0.85 | L3MBTL1 (0.43) | L3MBTL1GAAHSD17B10 | |
| SCHEMBL14740154 | 0.82 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL7196214 | 0.81 | L3MBTL1 (0.57) | L3MBTL1GAAHSD17B10ALOX12HDAC6 | |
| Silver SCHEMBL31293403 | 0.81 | L3MBTL1 (0.35) | L3MBTL1 | |
| SCHEMBL16134727 | 0.80 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10MEN1KMT2A | |
| SCHEMBL16134721 | 0.80 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10MEN1KMT2A | |
| SCHEMBL31402009 | 0.80 | L3MBTL1 (0.60) | L3MBTL1GAAHSD17B10ALOX12HDAC6 | |
| SCHEMBL5068576 | 0.80 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10ALOX12KMT2A | |
| SCHEMBL6675102 | 0.76 | L3MBTL1 (0.55) | L3MBTL1GAAHSD17B10HDAC6 | |
| SCHEMBL16279 | 0.76 | L3MBTL1 (0.55) | L3MBTL1GAAHSD17B10HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106823465-B | Mercaptobenzimidazole sulfonic acid type organic-inorganic hybridization monolithic column and preparation and application | 福州大学 | 2019-01-18 | — | — | CN | claimed |
| CN-106823465-A | Mercaptobenzimidazole sulfonic acid type organic inorganic hybridization integral post and preparation and application | 福州大学 | 2017-06-13 | — | — | CN | claimed |
| US-9428545-B2 | Process for isolation of plasma or serum proteins | THERAPURE BIOPHARMA INC. (CA) | 2016-08-30 | — | — | US | claimed |
| US-20160009757-A1 | PROCESS FOR ISOLATION OF PLASMA OR SERUM PROTEINS | THERAPURE BIOPHARMA INC. (CA) | 2016-01-14 | — | — | US | claimed |
| EP-1765866-B1 | ISOLATION OF PLASMA OR SERUM PROTEINS | THERAPURE BIOPHARMA INC (CA) | 2014-01-08 | — | — | EP | claimed |
| US-20130295646-A1 | METHOD FOR EXTRACTING A PROTEIN FROM MILK | LFB BIOTECHNOLOGIES (FR) | 2013-11-07 | — | — | US | claimed |
| US-20110163478-A1 | Porous Membrane and Recording Media Comprising Same | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2011-07-07 | — | — | US | claimed |
| EP-2051861-B1 | POROUS MEMBRANE AND ITS METHOD OF MANUFACTURE | FUJIFILM MFG EUROPE BV (NL) | 2011-03-23 | — | — | EP | claimed |
| EP-2632562-B1 | METHODS FOR CAPTURING VIRUS LIKE PARTICLES FROM PLANTS USING EXPANDED BED CHROMATOGRAPHY | PHILIP MORRIS PRODUCTS SA (CH) | 2020-08-05 | — | — | EP | disclosed |
| CN-106823465-B | Mercaptobenzimidazole sulfonic acid type organic-inorganic hybridization monolithic column and preparation and application | 福州大学 | 2019-01-18 | — | — | CN | disclosed |
| CN-106823465-B | Mercaptobenzimidazole sulfonic acid type organic-inorganic hybridization monolithic column and preparation and application | 福州大学 | 2019-01-18 | — | — | CN | disclosed |
| CN-106823465-B | Mercaptobenzimidazole sulfonic acid type organic-inorganic hybridization monolithic column and preparation and application | 福州大学 | 2019-01-18 | — | — | CN | disclosed |
| US-9782468-B2 | Purification of polysaccharide protein conjugates | SHANTHA BIOTECHNICS PRIVATE LIMITED (IN) | 2017-10-10 | — | — | US | disclosed |
| US-20170282095-A1 | Process For Isolation of Plasma or Serum Proteins | THERAPURE BIOPHARMA INC. (CA) | 2017-10-05 | — | — | US | disclosed |
| US-20040124149-A1 | Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays | CIPHERGEN BIOSYSTEMS, INC. | 2004-07-01 | — | — | US | disclosed |
| WO-2004024318-A1 | PREPARATION AND USE OF MIXED MODE SOLID SUBSTRATES FOR CHROMATOGRAPHY ADSORBENTS AND BIOCHIP ARRAYS | PALL CORPORATION (US) | 2004-03-25 | — | — | WO | disclosed |
| US-4324849-A | ESTABLISHING TEMPERATURE DIFFERENTIAL WITHIN TRANSPORT LIQUID ADJACENT RECORDING LAYER | EASTMAN KODAK COMPANY (US) | 1982-04-13 | — | — | US | disclosed |
| US-4269914-A | INCLUDING A LAYER TO RECEIVE AND IMMOBILIZE A DIFFUSIBLE DESENSITIZER ABLE TO EFFECT THE SENSITIVITY OF A SILVER HALIDE EMULSION TO ELECTROMAGNETIC RADIATION AND A BARRIER LAYER | EASTMAN KODAK COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| EP-0018268-A2 | Ultrasonographic elements containing multiple layers and process for preparing images | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1980-10-29 | — | — | EP | disclosed |
| US-4223082-A | ELECTROMAGNETIC WAVES | EASTMAN KODAK COMPANY (US) | 1980-09-16 | — | — | US | disclosed |